Article info

Download PDFPDF

Original research
Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study

Authors

  1. Correspondence to Dr Yi-Long Wu; syylwu{at}live.cn
View Full Text

Citation

Shen L, Guo J, Zhang Q, et al
Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study

Publication history

  • Accepted March 3, 2020
  • First published June 18, 2020.
Online issue publication 
June 18, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.